This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

The Modern Biology of Alpha Emitters: Biologically Optimized DNA Damage

The Modern Biology of Alpha Emitters: Biologically Optimized DNA Damage

1:30 pm - Wednesday 22nd July 2026

Exploring alpha emitter biology using lead-212 and astatine-211 beyond DNA damage
Linking molecular pathways to cellular response
Informing therapeutic strategies through mechanistic insights from lead-212 and astatine-211

Speakers:

David Mankoff

David Mankoff

Professor

University of Pennsylvania